A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial. (Q37048596)
Jump to navigation
Jump to search
scientific article published on 22 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial. |
scientific article published on 22 July 2013 |
Statements
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial (English)
José Baselga
Frederico Costa
Clifford A Hudis
Henri Roche
Lee S Schwartzberg
Oana Petrenciuc
Minghua Shan
William J Gradishar
1 reference
1 reference